(HealthDay)—The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.
(HealthDay)—The way you prepare broccoli and related vegetables can alter their potentially cancer-fighting powers, new research shows.
A team of scientists led by researchers from the University of California, San Diego School of Medicine and Ludwig Institute for Cancer Research have identified a novel therapeutic approach for the most frequent genetic cause ...
A drug approved for the treatment of rheumatoid arthritis may also turn out to be the first targeted therapy for one of the most common forms of kidney disease, a condition that almost inevitably leads to kidney failure. ...
The Food and Drug Administration is seeking a rule change to allow generic drugmakers to quickly update their warning labels with new safety information for doctors and patients.
(HealthDay)—Signing bonuses for primary care physicians are becoming ubiquitous in a competitive hiring landscape, according to an article published Oct. 25 in Medical Economics.
(HealthDay)—People with diets that promote inflammation—such as those high in sugar and saturated fats—are at increased risk for early death from all causes, including gastrointestinal tract cancers, a new study suggests.
(HealthDay)—Most individuals who participate in telephonic health coaching are satisfied and report that health coaching helped them achieve their weight-related goal, according to a study published Oct. 31 in the U.S. ...
(HealthDay)—Non-celiac wheat sensitivity (NCWS) may be a non-immunoglobulin E-mediated food allergy, according to a review published online Nov. 5 in the American Journal of Gastroenterology.
(HealthDay)—The life-threatening health problems that a 9-year-old boy with autism faced recently shed light on an issue that is rarely discussed.